National Wilm's Tumor Study Late Effects

Emory University

Status: Withdrawn

Conditions: Wilm's Tumor

Treatments: Other: none, screening only

Study type: Interventional

Funder types: Other

Identifiers

NCT00228696

IRB00024842

Details and patient eligibility

About

The Late Effects Study is being conducted in order to answer scientific questions and to serve as a resource for Wilms tumor patients and their families. Patients must have been enrolled on the NWTS-5 protocol in order to be eligible for this study.

Full description

The Late Effects Study is being conducted in order to answer scientific questions and to serve as a resource for Wilms tumor patients and their families. Although most people in this study enjoy good health, some may be at risk for certain health conditions. We are collecting information from as many participants as possible in order to determine if they or their offspring are at risk for adverse medical conditions. If there is more than one case of Wilms tumor in a given family, we plan to work with geneticists to try to estimate heritability and recurrence risks.

Sex: All

Ages: 18 to 85 years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

Previously enrolled in NWTS 5.

Trial design

Primary purpose: Screening

Allocation: Non-Randomized

Interventional model: Single Group Assignment

Masking: None (Open label)

---

0 participants in 1 patient group

screening

No Intervention group

Description:

this is a screening study and no intervention.

Treatment:

Other: none, screening only